Table of Contents
1 MARKET OVERVIEW
1.1 Pancreatic Beta-Cell Protection of Research
1.1.1 Definition
1.1.2 Specifications of Pancreatic Beta-Cell Protection
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 Stem Cell Based Overview
1.2.1.2 Gene Therapies Overview
1.2.1.3 RNA Based Therapies Overview
1.2.1.4 Monoclonal Antibodies (MAbs) Overview
1.2.1.5 Phytotherapy Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Hospital
1.3.1.2 Medical Research Laboratory
1.3.1.3 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 Stem Cell Based Market Size 2018-2023
3.1.1.1 Global Stem Cell Based Market Size and Growth Rate 2018-2023
3.1.1.2 Global Stem Cell Based Market Size by Region 2018-2023
3.1.2 Gene Therapies Market Size 2018-2023
3.1.2.1 Global Gene Therapies Market Size and Growth Rate 2018-2023
3.1.2.2 Global Gene Therapies Market Size by Region 2018-2023
3.1.3 RNA Based Therapies Market Size 2018-2023
3.1.3.1 Global RNA Based Therapies Market Size and Growth Rate 2018-2023
3.1.3.2 Global RNA Based Therapies Market Size by Region 2018-2023
3.1.4 Monoclonal Antibodies (MAbs) Market Size 2018-2023
3.1.4.1 Global Monoclonal Antibodies (MAbs) Market Size and Growth Rate 2018-2023
3.1.4.2 Global Monoclonal Antibodies (MAbs) Market Size by Region 2018-2023
3.1.5 Phytotherapy Market Size 2018-2023
3.1.5.1 Global Phytotherapy Market Size and Growth Rate 2018-2023
3.1.5.2 Global Phytotherapy Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 Stem Cell Based Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global Stem Cell Based Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global Stem Cell Based Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 Gene Therapies Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global Gene Therapies Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global Gene Therapies Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 RNA Based Therapies Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global RNA Based Therapies Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global RNA Based Therapies Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Monoclonal Antibodies (MAbs) Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Monoclonal Antibodies (MAbs) Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Monoclonal Antibodies (MAbs) Market Estimates and Forecasts by Region 2024E-2030F
3.2.5 Phytotherapy Market Estimates and Forecasts 2024E-2030F
3.2.5.1 Global Phytotherapy Market Forecasts and Growth Rate 2024E-2030F
3.2.5.2 Global Phytotherapy Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Hospital Market Size 2018-2023
4.1.1.1 Global Hospital Market Size and Growth Rate 2018-2023
4.1.1.2 Global Hospital Market Size by Region 2018-2023
4.1.2 Medical Research Laboratory Market Size 2018-2023
4.1.2.1 Global Medical Research Laboratory Market Size and Growth Rate 2018-2023
4.1.2.2 Global Medical Research Laboratory Market Size by Region 2018-2023
4.1.3 Others Market Size 2018-2023
4.1.3.1 Global Others Market Size and Growth Rate 2018-2023
4.1.3.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Hospital Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Hospital Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Hospital Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Medical Research Laboratory Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Medical Research Laboratory Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Medical Research Laboratory Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Others Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Pancreatic Beta-Cell Protection Market Competition
7.1.1 Global Pancreatic Beta-Cell Protection Market by Companies
7.1.2 Global Pancreatic Beta-Cell Protection Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 ViaCyte
8.1.1 ViaCyte Company Profile
8.1.2 ViaCyte Product Portfolio
8.1.3 ViaCyte Business Performance
8.1.4 ViaCyte Development Overview
8.2 PharmaCyte Biotech
8.2.1 PharmaCyte Biotech Company Profile
8.2.2 PharmaCyte Biotech Product Portfolio
8.2.3 PharmaCyte Biotech Business Performance
8.2.4 PharmaCyte Biotech Development Overview
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Company Profile
8.3.2 Boehringer Ingelheim Product Portfolio
8.3.3 Boehringer Ingelheim Business Performance
8.3.4 Boehringer Ingelheim Development Overview
8.4 GalaxoSmithKline
8.4.1 GalaxoSmithKline Company Profile
8.4.2 GalaxoSmithKline Product Portfolio
8.4.3 GalaxoSmithKline Business Performance
8.4.4 GalaxoSmithKline Development Overview
8.5 Beta-Cell NV
8.5.1 Beta-Cell NV Company Profile
8.5.2 Beta-Cell NV Product Portfolio
8.5.3 Beta-Cell NV Business Performance
8.5.4 Beta-Cell NV Development Overview
8.6 Novartis
8.6.1 Novartis Company Profile
8.6.2 Novartis Product Portfolio
8.6.3 Novartis Business Performance
8.6.4 Novartis Development Overview
8.7 Janssen Research & Development
8.7.1 Janssen Research & Development Company Profile
8.7.2 Janssen Research & Development Product Portfolio
8.7.3 Janssen Research & Development Business Performance
8.7.4 Janssen Research & Development Development Overview
8.8 Pfizer Inc
8.8.1 Pfizer Inc Company Profile
8.8.2 Pfizer Inc Product Portfolio
8.8.3 Pfizer Inc Business Performance
8.8.4 Pfizer Inc Development Overview
8.9 BioLineRx
8.9.1 BioLineRx Company Profile
8.9.2 BioLineRx Product Portfolio
8.9.3 BioLineRx Business Performance
8.9.4 BioLineRx Development Overview
8.10 Genentech
8.10.1 Genentech Company Profile
8.10.2 Genentech Product Portfolio
8.10.3 Genentech Business Performance
8.10.4 Genentech Development Overview
8.11 Novo Nordisk
8.11.1 Novo Nordisk Company Profile
8.11.2 Novo Nordisk Product Portfolio
8.11.3 Novo Nordisk Business Performance
8.11.4 Novo Nordisk Development Overview
8.12 Sanofi
8.12.1 Sanofi Company Profile
8.12.2 Sanofi Product Portfolio
8.12.3 Sanofi Business Performance
8.12.4 Sanofi Development Overview
8.13 Osiris Therapeutics
8.13.1 Osiris Therapeutics Company Profile
8.13.2 Osiris Therapeutics Product Portfolio
8.13.3 Osiris Therapeutics Business Performance
8.13.4 Osiris Therapeutics Development Overview
8.14 Beta-O2 Technologies Ltd
8.14.1 Beta-O2 Technologies Ltd Company Profile
8.14.2 Beta-O2 Technologies Ltd Product Portfolio
8.14.3 Beta-O2 Technologies Ltd Business Performance
8.14.4 Beta-O2 Technologies Ltd Development Overview
8.15 Transition Therapeutics
8.15.1 Transition Therapeutics Company Profile
8.15.2 Transition Therapeutics Product Portfolio
8.15.3 Transition Therapeutics Business Performance
8.15.4 Transition Therapeutics Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.